0
Editorials |

Bronchial Artery Embolotherapy for Control of Acute Hemoptysis : Analysis of Outcome

Robert I. White, Jr., MD
Author and Funding Information

Affiliations: New Haven, CT 
 ,  Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, CT.

Correspondence to: Department of Diagnostic Radiology, Yale University School of Medicine, 333 Cedar St, Room 5039 LMP, New Haven, CT 06520; e-mail: white@biomed.med.yale.edu



Chest. 1999;115(4):912-915. doi:10.1378/chest.115.4.912
Text Size: A A A
Published online

Extract

Life-threatening hemoptysis has a 30 to 40% operative mortality when treated surgically during the acute episode.1,,2 The description by Remy et al3 of bronchial artery embolotherapy (BAE) in 1973 provided a new interventional radiologic approach for managing hemoptysis and stabilizing the patient’s condition.3 Despite widespread use of the technique since the initial report, there are relatively few analyses of short-term (first 30 days) and long-term (1 to 2 years) outcomes of this therapy. In this issue of CHEST (see page 996), Mal et al attempted a difficult retrospective study of factors influencing outcome in 56 patients treated by BAE over 12 years. Some of their observations and prior work by others deserve further commentary.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543